Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
504studies shown
Showing 476-500 of 504
CompletedNCT04152629

Real World Evidence of the Efficacy and Safety of FOQUEST

This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand whether questionnaires and follow-up reports can improve sleep, daily rhythms, and longer-term stability.

ADHDOtherOver 6 Years
Countries
Canada
Sponsor
Purdue Pharma, Canada
Condition
ADHD
CompletedNCT01244490

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 17 Years
Countries
Austria, Canada, France, Germany, Ireland, Italy, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01106430

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Canada, Germany, Hungary, Italy, Poland, Spain, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT00997984

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

ADHDOtherFrom 6 Years to 12 Years
Countries
Canada, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT02827188

Cognitive Restructuring in ADHD: Functional Training

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 12 Years
Countries
Canada
Sponsor
The Hospital for Sick Children
Condition
ADHD
CompletedNCT02139124

The Efficacy and Safety of PRC-063 in Adult ADHD Patients

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand whether the medication PRC-063 can give earlier or clearer feedback during care.

ADHDOtherOver 18 Years
Countries
Canada, United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
CompletedNCT03335748

the Cogmed Program for Youths With ADHD

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 7 Years to 13 Years
Countries
Canada
Sponsor
Université du Québec a Montréal
Condition
ADHD
CompletedNCT02948270

Communication in Adolescents With ADHD

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 14 Years to 17 Years
Countries
Canada
Sponsor
The Hospital for Sick Children
Condition
ADHD
CompletedNCT01985581

Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 12 Years
Countries
Canada
Sponsor
JPM van Stralen Medicine Professional
Condition
ADHD
CompletedNCT01022229

The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 12 Years
Countries
Canada
Sponsor
The Canadian College of Naturopathic Medicine
Condition
ADHD
CompletedNCT02168127

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

This study exists to understand how the medication PRC-063 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication PRC-063 can improve attention, thinking, or day-to-day functioning.

ADHDOtherOver 12 Years
Countries
Canada, United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
CompletedNCT02139111

PRC-063 in Adolescent ADHD

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand whether the medication PRC-063 can give earlier or clearer feedback during care.

ADHDOtherFrom 12 Years to 17 Years
Countries
Canada, United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
CompletedNCT01886469

A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

ADHDOtherFrom 6 Years to 17 Years
Countries
Canada
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Condition
ADHD
CompletedNCT00922636

A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

This study exists to better understand the safety of the medication Pediatric and how manageable it feels in practice. Researchers are trying to understand whether the medication Pediatric can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 17 Years
Countries
Canada, United States
Sponsor
Eli Lilly and Company
Condition
ADHD